TY  - GEN
AU  - Bellido,Teresita
AU  - Ali,A Afshan
AU  - Plotkin,Lilian I
AU  - Fu,Qiang
AU  - Gubrij,Igor
AU  - Roberson,Paula K
AU  - Weinstein,Robert S
AU  - O'Brien,Charles A
AU  - Manolagas,Stavros C
AU  - Jilka,Robert L
TI  - Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism
SN  - 0021-9258
PY  - 2004///0115
KW  - Animals
KW  - Apoptosis
KW  - Blotting, Western
KW  - Bone Resorption
KW  - Calcium
KW  - metabolism
KW  - Carrier Proteins
KW  - Cells, Cultured
KW  - Core Binding Factor Alpha 1 Subunit
KW  - Culture Media, Conditioned
KW  - pharmacology
KW  - Cyclic AMP Response Element-Binding Protein
KW  - Cyclic AMP-Dependent Protein Kinases
KW  - Cysteine Endopeptidases
KW  - Dactinomycin
KW  - Female
KW  - HeLa Cells
KW  - Humans
KW  - Kinetics
KW  - Membrane Glycoproteins
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Models, Biological
KW  - Models, Genetic
KW  - Multienzyme Complexes
KW  - Neoplasm Proteins
KW  - Osteoblasts
KW  - Parathyroid Hormone
KW  - Phosphorylation
KW  - Proteasome Endopeptidase Complex
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - RANK Ligand
KW  - RNA
KW  - RNA, Messenger
KW  - Receptor Activator of Nuclear Factor-kappa B
KW  - Signal Transduction
KW  - Time Factors
KW  - Transcription Factors
KW  - Transcription, Genetic
KW  - bcl-Associated Death Protein
N1  - Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1074/jbc.M307444200
ER  -